Agomab Therapeutics NV SEC EDGAR Filings (CIK 0002020932)
SEC EDGAR filings, ownership reports, and insider transactions for Agomab Therapeutics NV.
-
Symbol
-
AGMB on Nasdaq
-
Business address
-
Posthoflei 1/6, Antwerpen, 2600
-
State of incorporation
-
Belgium
-
Fiscal year end
-
31 December
Agomab Therapeutics NV has filed 13 SEC EDGAR filings since 20 Jun 2024
Latest Filings
Recent SEC filings for Agomab Therapeutics NV
including
SCHEDULE 13G, 6-K, SCHEDULE 13D and more.
FAQ
- What is a CIK?
- A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
- Why are some filings missing?
- New filings appear as the SEC updates EDGAR, and older records can vary by availability.
- How often is this page updated?
- Updates follow new EDGAR submissions and periodic data refreshes.